diethylnitrosamine has been researched along with Metabolic Syndrome in 1 studies
Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herranz, D | 1 |
| Muñoz-Martin, M | 1 |
| Cañamero, M | 1 |
| Mulero, F | 1 |
| Martinez-Pastor, B | 1 |
| Fernandez-Capetillo, O | 1 |
| Serrano, M | 1 |
1 other study available for diethylnitrosamine and Metabolic Syndrome
| Article | Year |
|---|---|
Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.
Topics: Aging; Animals; Dietary Fats; Diethylnitrosamine; DNA Damage; Female; Glucose Tolerance Test; Liver | 2010 |